|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00673 CHINA HEALTH
Nominal 
0.370 -0.330 (-47.143%) | 2024/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | |
| Turnover | 18,680 | -33.918% | 59,930 | 76,414 | 107,025 | 87,889 |
| Cost of Sales | (16,687) | -28.175% | (46,292) | (49,222) | (78,336) | (61,897) |
| Gross Profit | 1,993 | -60.417% | 13,638 | 27,192 | 28,689 | 25,992 |
| 2024/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | (4,000) | 0 | 0 | |
| Profit / (Loss) before Taxation | (17,607) | 6.806% | (42,294) | (39,383) | (8,709) | (5,331) | |
| Taxation | (17) | -69.643% | (203) | (177) | (405) | (1,228) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 237 | -83.997% | 2,310 | (2,486) | (3,091) | (1,185) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (17,387) | 15.452% | (40,187) | (42,046) | (12,205) | (7,744) | |
| 2024/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | |
| Net Finance Costs / (Income) | (451) | 355.556% | (593) | 1,754 | (40) | (4,849) |
| Depreciation & Amortisation | 944 | -45.747% | 4,548 | 4,152 | 4,031 | 3,571 |
| Directors' Emoluments | -- | -- | 3,236 | 3,251 | 4,240 | 5,184 |
| 2024/09 - Interim | %Chg (Compare to Interim) | 2024/03 | 2023/03 | 2022/03 | 2021/03 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/09 - Interim | %Chg (Compare to Interim) | 2024/03 | 2023/03 | 2022/03 | 2021/03 | |
| EPS (cts) | -3.590 | 12.539% | -8.450 | -9.860 | -2.960 | -1.900 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.013) | (0.046) | 0.077 | (0.022) |
| NBV per share ($) | 0.089 | -- | 0.109 | 0.180 | 0.181 | 0.230 |
| Remarks: | Real time quote last updated: 27/12/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -17,387,000 |
| %Change | 15.452% |
| EPS / (LPS) | HKD -0.036 |
| NBV Per Share ($) | HKD 0.089 |